Status | Study |
Recruiting |
Study Name: Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource Condition: Plasma Cell Dyscrasias Monoclonal Gammopathy of Undetermined Significa Date: 2011-08-01 Interventions: Procedure: tissue banking tissue procurement for this protocol will occur at the time of initial diagnos |
Completed |
Study Name: Imaging in MGUS, SMM and MM Condition: Multiple Myeloma Smoldering Multiple Myeloma Date: 2010-11-06 Interventions: Drug: 18-NaF PET The patient w |
Completed |
Study Name: A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma Condition: Monoclonal Gammopathy of Undetermined Significance Multiple Mye Date: 2010-09-23 Interventions: Biological: Siltuximab 15mg/kg IV infusion every 3 weeks for 4 cycles. If applicable extended dosing of |
Completed |
Study Name: Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM) Condition: Smoldering Myeloma Monoclonal Gammopathy of Undetermined Significance Date: 2010-04-22 |
Active, not recruiting |
Study Name: Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM. Condition: Monoclonal Gammopathy of Undetermined Significance Smoldering M Date: 2010-03-01 Interventions: Genetic: Genetic study of DNA copies Gene expression profiling, DNA copy number variation |
Terminated |
Study Name: Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma Condition: Multiple Myeloma and Plasma Cell Neoplasm Precancerous Condition Date: 2009-07-17 Interventions: Dietary Supplement: defined green tea catechin extract |
Completed |
Study Name: S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS. Condition: Multiple Myeloma Smoldering Myeloma Waldenstrom's Macroglo Date: 2009-06-11 Interventions: Other: biologic sample preservation procedure Blood and 3-4 cc bone marrow aspirate collected at same ti |
Completed |
Study Name: S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma Condition: Multiple Myeloma Plasma Cell Myeloma Precancerous Conditio Date: 2009-05-09 Interventions: Genetic: cytogenetic analysis Genetic: mic |
Terminated |
Study Name: Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM) Condition: Monoclonal Gammopathy of Undetermined Significance Smoldering M Date: 2009-05-08 Interventions: Dietary Supplement: Omega 3 Fatty Acid Omega 3 supplementation will be initiated at three 1250 mg capsul |
Suspended |
Study Name: Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance Condition: Neuropathy Nonmalignant Monoclonal Gammopathy of Undetermined Signific Date: 2008-04-22 Interventions: Drug: Lenalidomide Subjects will receive lenalidomide 25 mg per day for days 1-21 followed by 7 days res |